ArticleBioinformatics advances2025
Unveiling novel drug-target couples: an empowered automated pipeline for enhanced virtual screening using AutoDock Vina.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anisodine hydrobromide targets matk and prevents delayed rtPA thrombolysis-induced vasogenic cerebral edema in ischemic stroke.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Drug repurposing offers a cost-effective and time-efficient strategy for identifying new therapeutic uses for existing medications, capitalizing on their known safety profiles and pharmacokinetics. We present an automated virtual screening pipeline using AutoDock Vina, a molecular docking software that predicts how small molecules bind to protein targets. This pipeline enhances the speed and accuracy of drug candidate identification by automating and parallelizing the docking process. Results: We developed and validated a fully automated virtual screening pipeline based on AutoDock Vina, enabling computational parallelization and random ligand positioning without relying on prior knowledge of biologically active protein domains. As a proof of concept, the pipeline was applied to the "serotonin and anxiety" pathway. Docking results were compared with known drug-target interactions, demonstrating the ability of the pipeline to reliably identify compounds interacting with serotonin receptors. This case study confirms the pipeline's effectiveness in supporting drug repurposing by identifying promising candidates for further experimental validation. Availability and implementation: The AutoDock Vina automation pipeline is freely available for noncommercial use at https://gitlab.com/la_sveva/pip2.0. It is compatible with Linux systems, and a Docker image is provided for ease of deployment and reproducibility. Researchers can easily integrate the pipeline into existing workflows, supporting broader adoption in virtual screening and drug repurposing projects.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.